Pharmacologic Closure of Patent Ductus Arteriosus in the Premature Infant

New England Journal of Medicine

Volumn 295, Issue 10, 1976, Pages 526-529

  Friedman, William F ^a   Hirschklau, Michael J ^a   Printz, Morton P ^a   Pitlick, Paul T ^a   Kirkpatrick, Stanley E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

CHILD; CLINICAL STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG THERAPY; DUCTUS ARTERIOSUS OBLITERATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RECTAL DRUG ADMINISTRATION; THERAPY;

EID: 0017124337     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197609022951003     Document Type: Article

References (31)

1. Thibeault DW, Emmanouilides GC, Nelson RJ, et al: Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. J Pediatr 86: 120–126, 1975
2. Neal WA, Messenger FB Jr, Hunt CE, et al: Patent ductus arteriosus complicating respiratory distress syndrome. J Pediatr 86: 127–131, 1975
3. Zachman RD, Steinmetz GP, Botham RJ, et al: Incidence and treatment of the patent ductus arteriosus in the ill premature neonate. Am Heart J 87: 697–703, 1974
4. Elliott RB, Starling MB, Neutze JM: Medical manipulation of the ductus arteriosus. Lancet 1: 140–142, 1975
5. Olley PM: Nonsurgical palliation of congenital heart malformations. N Engl J Med 292: 1292–1294, 1975
6. Olley PM, Coceani F, Bodach E: E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations. Circulation 53: 728–731, 1976
7. Heymann MA, Rudolph AM: Dilatation of the ductus arteriosus in infants with pulmonic atresia. Pediatr Res 10: 313, 1976
8. Flower RJ, Vane JR: Inhibition of prostaglandin biosynthesis. Biochem Pharmacol 23: 1439–1450, 1974
9. Sahn DJ, Vaucher Y, Williams DE, et al: Echocardiographic detection of large left to right shunts and cardiomyopathies in infants and children. Am J Cardiol (in press)
10. Silverman NJ, Lewis AB, Heymann MA, et al: Echocardiographic assessment of ductus arteriosus shunts in premature infants. Circulation 50: 821–825, 1974
11. Baylen BG, Meyer RA, Kaplan S, et al: The critically ill premature infant with patent ductus arteriosus and pulmonary disease: an echocardiographic assessment. J Pediatr 86: 423–432, 1975
12. Friedman WF, Hirschklau MJ, Pitlick PT, et al: Pharmacological closure of patent ductus in the premature. Pediatr Res 10: 312, 1976
13. Hunt CE, Matalon S, Wangensteen OD, et al: Mass spectrometer evaluation of ventilation-perfusion abnormalities in respiratory distress syndrome. Pediatr Res 8: 621–627, 1974
14. Hagan AD, Deely WJ, Sahn D, et al: Echocardiographic criteria for normal newborn infants. Circulation 48: 1221–1226, 1973
15. Sahn DJ, Deely WJ, Hagan AD, et al: Echocardiographic assessment of left ventricular performance in normal newborns. Circulation 49: 232–236, 1974
16. Weeks JR: Prostaglandins. Annu Rev Pharmacol 12: 317–336, 1972
17. Higgins CB, Braunwald E: The prostaglandins: biochemical, physiological and clinical considerations. Am J Med 53: 92–112, 1972
18. Starling MB, Elliott RB: The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro. Prostaglandins 8: 187–203, 1974
19. Sharpe GL, Thalme B, Larsson KS: Studies on closure of the ductus arteriosus. XL Ductal closure in utero by a prostaglandin synthetase inhibitor. Prostaglandins 8: 363–368, 1974
20. Sharpe GL, Larsson KS, Thalme B: Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins 9: 585–596, 1975
21. Heymann MA, Rudolph AM: Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Cire Res 38: 418–422, 1976
22. Traeger A, Nöschel H, Zaumseil J: Zur Pharmakokinetik von Indomethazin bei Schwangeren, Kreissenden und deren Neugeborenen. Zentralbl Gynaekol 95: 635–641, 1973
23. Zuckerman H, Reiss U, Rubinstein I: Inhibition of human premature labor by indomethacin. Obstet Gynecol 44(6):787–792, 1974
24. Arcilla RA, Thilenius OG, Ranniger K: Congestive heart failure from suspected ductal closure in utero. J Pediatr 75: 74–78, 1969
25. Koch-Weser J, Sellers EM: Binding of drugs to serum albumin. N Engl J Med 294: 311–316, 526–531, 1976
26. Kocsis JJ, Hernandovich J, Silver MJ, et al: Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins 3: 141–144, 1973
27. McGiff JC, Crowshaw K, Itskovitz HD: Prostaglandins and renal function. Fed Proc 33: 39–47, 1974
28. McGiff JC, Nasjletti A: Kinins, renal function and blood pressure regulation. Fed Proc 35: 172–174, 1976
29. Duggan DE, Hogans AF, Kwan KC, et al: The metabolism of indomethacin in man. J Pharmacol Exp Ther 181: 563–575, 1972
30. Kwan KC, Breault GO, Umbenhauer ER, et al: The kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man. J Pharmacokinet Biopharm (in press)
31. Heymann MA, Rudolph AM, Silverman NH: Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295: 530–533, 1976